How the medication affects you will be different than someone else
The trial demonstrated dose-dependent weight loss, with participants receiving 12 mg achieving a mean body weight reduction of approximately 24% over 48 weeks a result that has attracted considerable scientific and public interest
First, let me caution that this is just a mouse study, so it may not hold true in humans
Covers nausea rates from pooled STEP and SURMOUNT data, why patients discontinue, the lean mass question, gallbladder and pancreatitis risk, the thyroid boxed warning, and what happens after stopping
Online health platform Noom recently launched its Noom Microdose GLP-1 Rx Program to reportedly address barriers to GLP-1s, including medication cost
Taming the Tummy Troubles: Eating to Minimize Side Effects One of the most discussed aspects of GLP-1 therapy is the potential for gastrointestinal (GI) side effects